Sonia Selletti
e-mail: sonia.selletti@studiolegaleastolfi.it
Born in Borgosesia (VC) on 16 October 1967, she graduated in Law from the University of Pavia in 1991.
She has been a member of the Milan Bar Association since 1995 and is authorised to practice at the Italian Supreme Court of Cassation since 2007.
She mainly works in pharmaceutical and health law, cosmetic products, health supplements, and medical devices (life sciences).
She chairs the Supervisory Bodies of a number of pharmaceutical and medical companies under Legislative Decree 231/2001.
She also provides judicial and extra-judicial assistance and consultancy to companies and trade associations that mainly operate in the pharmaceutical, medical devices, health food products and cosmetics sectors.
She has collaborated with the Faculty of Political Sciences of the University of Pavia, giving lectures as part of the administrative law course on procedures for access to the pharmaceuticals market.
She holds lectures at conventions and congresses and provides instruction in pharmaceutical and medical law, also to medical workers for the purposes of ECM (ongoing education in medicine).
She has been a partner of Studio Legale Astolfi e Associati law firm of since 1995, serves as editor-in-chief of the legal journal "Rassegna di diritto farmaceutico e della salute", and has authored several publications, including the recent: International Comparative Legal Guides “Legal impact analysis: strategic and sustainable management in Drug and Medical Device Litigation. Italian jurisdction perspective” (2022); International Comparative Legal Guides “Digital Health”, Second Edition (2022); “Global Legal Insights: Pricing & Reimbursement 2021 – Fourth edition”, (2021), The International Comparative Legal Guide to: Pharmaceutical Advertising”, A practical cross-border insight into pharmaceutical advertising, Italian Chapter, GlG, (2021), Legal prospective on anti-ageing Cosmetic claims: how to convey clear messages to Consumers”, Ed. Elsevier, (2020), “Patient Support Program. Cosa permette la legge”, AboutPharma, (2020), "La nuova governance della spesa farmaceutica - Una prima lettura “a caldo” della legge n. 145/2018", in Rassegna di diritto farmaceutico e della salute, 2019; “EU Cosmetic Regulation: quality enhancement of consumer and environment protection, market development”, in Bionanotechnology to Save the Environment, 2019; “L’impatto della nuova normativa privacy sugli studi clinici”, in Rassegna di diritto farmaceutico e della salute, 2018; “Italy: Pharmaceutical Advertising 2018" in The International Comparative Legal Guide to Pharmaceutical Advertising, 2018; and “Biosimilar switching and related medical liability”, in Journal of Forensic and Legal Medicine – Elsevier, 2018.
Member of the Board of Directors of Gruppo Villa Maria S.p.a. and Formec Biffi S.p.a.
Vice President of the non-profit organisation Fondazione UBI Banca Popolare Commercio & Industria onlus.
Languages: Italian, English, Spanish and French.
